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Abstract 
Background: Measles is a highly contagious viral illness which results in high morbidity and mortality rates 
among affected population especially children under 5 years of age. Hence our study evaluate the impact of 
measles supplementary immunization activity campaign of 2018 on children health and control of measles in 
district Rawalpindi, Pakistan. 
Methods: This prospective analytical case study was conducted at Allied teaching hospitals of Rawalpindi 
Medical University Rawalpindi, from January 2019 to March 2019. One month to 10 years old children presenting 
with measles and its complications, were hospitalized and subsequently enrolled in the study. The measles cases 
presented during the study period were compared with the measles cases reported to the Allied Hospitals of 
Rawalpindi medical university during the same time period in 2018.Data on the campaign implementation and 
measles surveillance was reviewed and analyzed by statistical methods using SPSS 22. 
Results: 53 cases of measles were reported during the study period (Jan-Mar 2019) compared to 405 cases in the 
same time period of 2018. Rapid coverage surveys showed that 98.09% of children were vaccinated during the 
campaign. From Jan to March 2019, after the campaign, the number of measles cases was reduced by 86.91% 
compared with the same period of 2018 with significant decrease in mortality and morbidity. 
Conclusions: A massive vaccination campaign approach for controlling measles in Rawalpindi with a vast 
migrant population has proved effective.  
Keywords: Measles, Audit, SIA, complications, outcomes, vaccination, Children. 
 
 
Introduction 
Measles is a highly contagious viral illness which 
results in high morbidity and mortality rates among 
affected population especially children under 5 years 
of age.1 Before the introduction of measles vaccine in 
1963, around 90% of children worldwide were infected 
with measles before their 15th birthday resulting in 
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>90% deaths annually.2 But the post vaccine era saw a 
dramatic reduction in measles associated morbidity 
and mortality by 74% and 85% respectively.3 
According to Global Measles & Rubella Strategic Plan 
2012-2020, the target is to achieve measles and rubella 
elimination in at least five WHO regions by 2020.4 
Strengthening of immunization systems is essential for 
achieving these elimination goals. Nationwide 
supplementary immunization activities (SIA) 
conducted to increase immunity levels in susceptible 
populations is one of the key strategies in achieving 
the target of measles elimination. Measles 
supplementary immunization activities (SIAs) are 
campaigns that supplement routine vaccination 
programs with a recommended additional dose for 
children of different ages, without taking in account 
their previous vaccination status.5 They are conducted 
every 2-4 years and over a few weeks, mainly in 
resource poor countries of South East Asia and Africa.6 
Despite the SIAs having high vaccination rates, it still 
needs to be documented and confirmed whether they 
reach the children who miss their routine measles 
vaccine dose. Determining the population covered by 
SIAs is vital to understanding their effectiveness, as 
well as to measure progress towards measles control. 
WHO is the lead technical agency responsible for 
coordination of immunization and surveillance 
activities, with an aim of achieving a world free from 
measles. World Health Organization (WHO) and 
United Nations Children's Fund (UNICEF) joined the 
Government of Pakistan in kick-starting a nationwide 
measles campaign to vaccinate more than 32 million 
children, one sixth of the population of Pakistan in 
October 2018.7 
In district Rawalpindi, measles SIA was conducted in 
the month of October (15-27) 2018. During this 12 days 
drive, 890580 children aged six months to 7 years were 
vaccinated out of the tentative target of 852554. A total 
of 3200 health care officials took part in this activity 
comprising 663 outreach and 221 fixed teams that 
approached every house hold in the district to 
vaccinate the children.8 
We analyzed the measles cases reporting to the Allied 
Hospitals of Rawalpindi Medical university from Jan 
2019 to March 2019 and compared with the measles 
cases reported to these hospitals of Rawalpindi during 
the same period in 2018. 
 
 
Materials and Methods 
 
This prospective analytical study was conducted at 
Allied teaching hospitals of Rawalpindi medical 
University Rawalpindi, from January 2019 to March 
2019. One month to 10 years old children presenting 
with measles and its complications, were hospitalized 
and subsequently enrolled in the study. The measles 
cases presented during the study period were 
compared with the measles cases reported to the 
Allied Hospitals of RMU Rawalpindi during the same 
period in 2018. 
The data was entered and analyzed by using SPSS 
version 22 software. The descriptive analysis was done 
in terms of pre and post campaign cases in same time 
period of the years for age, gender, measles 
complications and outcomes.  The mean with standard 
deviation, median, frequency and percentages were 
reported. The Pearson Chi-square test was used to test 
for differences between the cases, complications and 
outcomes in measles before and after the campaign. A 
p-value of less than 0.05 was considered significant. 
Only cases resident of district Rawalpindi were 
included in this study 
 
Result 
 
Total of fifty three cases were reported from Jan to 
Mar 2019 from all teaching hospitals of district 
Rawalpindi while in the same time period of year 
2018, 405 cases of suspected measles were reported. 
This sharp decline in the number of cases reported 
signifies an 86.7% decline in incident rate of measles in 
district Rawalpindi in the post SIA-2018 period.  
 
Demographic profile Pre- SIA (Jan- 
Mar) 
Post SIA 
(Jan-Mar) 
2019) 
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 2018 
N = 405 
N = 53 
Age  in months 
Mean (SD) 26.08 ± 29.4 10 ± 21.78 
Median (IQR) 18 10 
Age  in categories 
Up to 12 m 216 (53%) 32 (60.5%) 
1 – 5 years 145 (36%) 13 (24.5%) 
5 – 10 years 44 (11%) 8 (15%) 
Gender 
Male 228 (56.3%) 30 (56.6%) 
Female 178 (43.7%) 23 (43.4%) 
 
The mean age of measles suspects in 2018 was 
observed to be 26.08 months (SD 29.4), while it 
significantly declined post SIA to mean age of 10 
months (SD 21.78). However no major change in the 
age groups was observed pre and post campaign. The 
male to female ratio remained almost same at 1:1.3   
  Table 2: MEASLES CASES PRE AND POST SIA 2018 
Measles 
cases 
2018 2019 
Jan Fe
b 
Mar Total Jan Fe
b 
Mar Total 
BBH 26 97 117 240 05 06 19 30 
HFH 24 53 73 150 08 07 06 21 
DHQ 00 09 06 15 00 02 00 02 
TOTAL 405 53 
 
 Frequency distribution of complications 
related to Measles showed 87% decline in pneumonia, 
gastroenteritis and otitis media. However, the 
complication rates for these conditions remained 
almost the same. No case of measles encephalitis was 
reported in post SIA period with mortality declined 
from seven in pre measles SIA period to zero post 
measles SIA period.  
 
Table 2: Complications 
Complications JAN-MAR 
2018 
JAN-MAR 
2019 
Pneumonia 187 (46.2%) 23 (43.4%) 
Gastroenteritis 91 (22.5%) 11 (20.7%) 
Otitis Media 54 (13.4%) 07 (13.2%) 
Encephalitis 1 00 
Expired 07 (1.8%) 00 
Discussion 
Global vaccine action plan(GVAP) has targeted for 
measles to be eliminated from 5 WHO regions by 2020. 
For termination of endemic measles transmission, at 
least 95% coverage with 2 doses of measles containing 
vaccine is required in every district.9 One of the key 
strategies for successful elimination of measles has 
been SIAs, including catch-up and follow-up 
vaccination programs.10 During 2000–2017, coverage 
for 1st and 2nd dose of measles vaccine in Pakistan 
increased considerably, to 76% and 45%, respectively, 
but is still well below the WHO-recommended level of 
≥95%. Moreover, measles epidemics occurred during 
2012–2014 and 2016–2018, revealing coverage gaps 
from both routine immunization services and 
SIAs.11Our study looked at the cases of complicated 
measles admitted into the pediatric wards of all 
tertiary care hospitals of Rawalpindi over a period of 
three months. Retrospective hospitals records were 
compared for the same period of last year before the 
commencement of supplemental measles 
immunization campaign. We noticed a significant 
reduction in the proportion of measles cases admitted 
in the periods after the introduction of the SIAs. 
Routine immunization coverage rate in Rawalpindi for 
measles immunization remained the same for the year 
2018-19 during the study period.8 Since no significant 
change was observed in the routine immunization 
coverage rate, total number of children admitted 
before and after SIA as well as other childhood health 
interventions including the strengthening of 
surveillance system, this remarkable reduction in the 
number of admitted measles cases observed in this 
study can only be due to the supplemental measles 
immunization campaign. This finding is in keeping 
with similar observations across the world.11,12,13 
In this study, a substantial reduction in the number of 
measles cases was found following the implementation 
of SIA in the District. There was a dramatic reduction 
in the incidence of measles in Rawalpindi. SIAs have 
been shown to play a key role in eliminating measles 
in the Americas14, and in reducing the incidence of 
disease in Eastern Europe.15 A study of 15 province-
wide SIAs in China during 2004–2008 found that there 
was on average an 88.1% decrease in measles 
incidence the year after an SIA compared to the 
average rate in the preceding 5 years. Measles cases 
also significantly declined (89% average reduction) 
following SIAs in 12 eastern and western African 
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countries in 2000-200316. In Ethiopia, reported measles 
cases declined 93% from after a large national catch-up 
campaign in 2003-2004. In southern Africa, a 
vaccination strategy including routine immunization, 
mass catch-up SIAs, and regular follow-up SIAs in six 
countries reduced reported measles incidence from 
60,000 cases in 1996 to 117 cases in 2000.16 
Especially for countries and regions with less capacity 
to reliably deliver vaccines through routine 
immunization services, SIAs appear to be a cost-
effective method to distribute the second dose of 
measles vaccine17. 
No studies have been conducted to evaluate the 
sensitivity and health impact of measles survellience 
and completion of measles reporting in Rawalpindi is 
unknown. The consistency of the case reporting over 
the years, however, makes these RMU hospitals a 
valid source to examine the trend of measles. No data 
on sero-conversion rates following SIAs was available, 
which greatly limited our ability to assess the effect of 
SIAs on the dynamics of infection and immunity. 
Perhaps the greatest limitation of the current study 
was that it was an observational study. Nevertheless, it 
is ethically unacceptable to conduct an experimental 
study in public health to assess the effectiveness of an 
intervention with an already well-established benefit. 
It is also beyond the scope of the current study to 
evaluate the cost-effectiveness of SIAs. With these 
limitations in mind, we believe, to the best of our 
knowledge, that the current study is the first to 
document an immunization campaign conducted in 
district Rawalpindi to measure the outcome of SIA in 
terms of reduction in childhood morbidity and 
mortality.  
 
Conclusion 
The measles SIA-2018 has proved effective for district 
Rawalpindi to control the measles outbreak and also to 
limit the mortality and morbidity associated with 
measles in children of Rawalpindi.  
To achieve measles elimination, serious efforts are 
needed to increase the coverage of 1st and 2nd dose of 
measles vaccine, development of strategies to identify 
and reach the population not accessing immunization 
services especially poor communities and rural areas, 
and increase sensitivity of case-based measles 
surveillance in all districts. One such effort can be 
conduction of regular high quality SIAs based on 
WHO SIA guidelines, to ensure ≥95% 2 dose measles 
vaccine coverage. 
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